维普中文期刊产品整合服务
8篇 您的检索式:作者名="PEREZ GC"
    题名 作者 年代 出处 被引量
1Prognosis of cognition in congenital hypothyroidism following early treatment显示文摘ALVAREZ GMA CARVAJAL MF PEREZ GC 2004Rev Neurol2004,38,6:1
2Effect of triterpe- noids of bouvardia terniflora on blood sugar levels of nor- mal and alloxan diabetic mice显示文摘Perez GRM Perez GC Perez GS 1998Phytomedicine1998,5,6:1
3Effect of triterpenoids of Bouvardin temiflora on blood sugar levels of nor- mal and alloxan diabetic mice 显示文摘Perez GRM Perez GC Perez GS 1998Phytomedicine1998,5,6:1
4Effect of triterponoids of Bouvardia terniflora on blood sugar levels of normal and alloxan diabetic mice显示文摘Perez GRM Perez GC Perez GS 1998Phytomedicine1998,5,6:1
5LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56 CD8+ natural killer cells显示文摘Perez OD Mitehell D Jager GC 2004Blood2004,104,4:1
6Antifungal activity of seselin in protecting stored maize from Aspergillusflavus 显示文摘Cardenas ONC Perez GC Perez GS 2007Asian J Plant Sci2007,6,:1
7A review onthe dietary flavonoid kaempferol显示文摘Calderon-Monta-o JM Burgos ME Perez GC 2011Mini Rev Med Chem2011,11,4:1
8Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents:EPIC05-Sierra75 study显示文摘OBJECTIVES Elderly patients show a higher incidence of ischemic and bleeding events after percutaneous transluminal coron-ary intervention(PCI).We sought to investigate outcomes in elderly patients treated with antithrombotic strategy guided by bleeding and ischemic risks after revascularization with last generation everolimus-eluting stent(EES).METHODS Prospective multicenter registry including patients over 75 years revascularized with EES and antithrombotic ther-apy guided by clinical presentation,PCI complexity and PRECISE DAPT score.Co-primary safety endpoints were:(1)composite of cardiac death,myocardial infarction and stent thrombosis and;(2)bleeding(BARC 2-5).Primary efficacy endpoint was target lesion revascularization.A matched group of patients revascularized with current drug-eluting stents and no such tailored antith-rombotic therapy was used as control.RESULTS Finally,1064 patients were included in SIERRA-75 cohort,80.8±4.2 years,36.6%women,71%acute coronary syn-dromes(ACS)and 53.6%complex PCI.Co-primary safety endpoint of major adverse cardiovascular events was met in 6.2%,co-primary safety endpoint of bleeding in 7.8%and primary efficacy endpoint of TKLR in 1.5%.The multivariable adjusted model showed no significant association of the prescribed short/long dual antiplatelet therapy(DAPT)durations with any endpoint suggesting a well tailored therapy.No stent thrombosis reported in the subgroup with 1-3 months DAPT duration.As compared to control group,bleeding BARC 2-5 was significantly lower in SIERRA-75 group(7.4%vs.10.2%,P=0.04)as well as the net safety-efficacy endpoint(14.3%vs.18.5%,P=0.02).CONCLUSIONS In elderly population,the application of this risks-adjusted antithrombotic protocol after revascularization with last generation EES seems to be associated with an improved prognosis in terms of ischemic and bleeding outcomes.Jose M de la Torre Hernandez Ramon Lopez Palop Jesus M Jimenez Mazuecos Pilar Carrillo Sáez Alejandro Gutierez-Barrios Eduardo Pinar Belen Cid Luis Fernandez Tamara Garcia Camarero Cristóbal Urbano-Carrillo Juan F Oteo Dominguez Victor A Jimenez Diaz Antonio EGomez Menchero Eladio Galindo Fernández Juan GCórdoba Soriano Raymundo Ocaranza Eduardo ArroyoÚcar Koldobika Garcia San Roman Silvio Leal Ginés Martínez Cáceres Jose A Linares Vicente Georgina Fuertes Ferre Xavier Carrillo Juan CRama Merchán Catia Costa Juan Sanchis Renato Fernandes Alberto Rodrigues Jose M Vegas Valle Hélder Pereira Armando Perez de Prado 2022Journal of Geriatric Cardiology2022,19,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费